Literature DB >> 25736725

Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation.

Frank Bode1, Oliver Blanck2, Maximilian Gebhard3, Peter Hunold4, Martin Grossherr5, Sebastian Brandt5, Reinhard Vonthein6, Holger Thiele7, Juergen Dunst2, Dirk Rades2.   

Abstract

AIMS: Electrical isolation of the pulmonary veins (PVs) has been established in clinical routine as a curative treatment for atrial fibrillation (AF). While catheter ablation carries procedural risks, radiosurgery might be able to non-invasively induce lesions at the PV ostia to block veno-atrial electrical conduction. This porcine feasibility and dose escalation study determined the effect of radiosurgery on electrophysiologic properties of the left atrial-PV junction. METHODS AND
RESULTS: Eight adult Goettingen mini-pigs underwent electrophysiological voltage mapping in the left atrium and the upper right PV. Radiation was delivered with a conventional linear accelerator. A single homogeneous dose ranging from 22.5 to 40 Gy was applied circumferentially to the target vein antrum. Six months after radiosurgery, electrophysiological mapping was repeated and a histological examination performed. Voltage mapping consistently showed electrical potentials in the upper right PV at baseline. Pacing the target vein prompted atrial excitation, thus proving veno-atrial electrical conduction. After 6 months, radiation had reduced PV electrogram amplitudes. This was dose dependent with a mean interaction effect of -5.8%/Gy. Complete block of atrio-venous electrical conduction occurred after 40 Gy dose application. Histology revealed transmural scarring of the targeted PV musculature with doses >30 Gy. After 40 Gy, it spanned the entire circumference in accordance with pulmonary vein isolation.
CONCLUSION: Pulmonary vein isolation to treat AF can be achieved by radiosurgery with a conventional linear accelerator. Yet, it requires a high radiation dose which might limit clinical applicability. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Pulmonary vein isolation; Radiation; Radiosurgery

Mesh:

Year:  2015        PMID: 25736725     DOI: 10.1093/europace/euu406

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  14 in total

Review 1.  Magnetic resonance image guidance in external beam radiation therapy planning and delivery.

Authors:  Ilamurugu Arivarasan; Chandrasekaran Anuradha; Shanmuga Subramanian; Ayyalusamy Anantharaman; Velayudham Ramasubramanian
Journal:  Jpn J Radiol       Date:  2017-06-13       Impact factor: 2.374

Review 2.  Stereotactic radioablation for ventricular tachycardia.

Authors:  Stephan Hohmann; Henrike A K Hillmann; Johanna Müller-Leisse; Jörg Eiringhaus; Christos Zormpas; Roland Merten; Christian Veltmann; David Duncker
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-11-26

3.  Stereotactic Radiotherapy Ablation and Atrial Fibrillation: Technical Issues and Clinical Expectations Derived From a Systematic Review.

Authors:  Jessica Franzetti; Stefania Volpe; Valentina Catto; Edoardo Conte; Consiglia Piccolo; Matteo Pepa; Gaia Piperno; Anna Maria Camarda; Federica Cattani; Daniele Andreini; Claudio Tondo; Barbara Alicja Jereczek-Fossa; Corrado Carbucicchio
Journal:  Front Cardiovasc Med       Date:  2022-05-03

4.  Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery) : First-in-patient treatment in Germany.

Authors:  David Krug; Oliver Blanck; Thomas Demming; Matthias Dottermusch; Karoline Koch; Markus Hirt; Laura Kotzott; Adrian Zaman; Lina Eidinger; Frank-Andre Siebert; Jürgen Dunst; Hendrik Bonnemeier
Journal:  Strahlenther Onkol       Date:  2019-10-31       Impact factor: 3.621

5.  Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity-modulated proton therapy.

Authors:  Xue-Ying Ren; Peng-Kang He; Xian-Shu Gao; Zhi-Lei Zhao; Bo Zhao; Yun Bai; Si-Wei Liu; Kang Li; Shang-Bin Qin; Ming-Wei Ma; Jing Zhou; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2021-04-04       Impact factor: 2.102

6.  Early Changes in Rat Heart After High-Dose Irradiation: Implications for Antiarrhythmic Effects of Cardiac Radioablation.

Authors:  Myung-Jin Cha; Jeong-Wook Seo; Hak Jae Kim; Moo-Kang Kim; Hye-Sun Yoon; Seong Won Jo; Seil Oh; Ji Hyun Chang
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

7.  Treatment Planning Considerations for Robotic Guided Cardiac Radiosurgery for Atrial Fibrillation.

Authors:  Oliver Blanck; Svenja Ipsen; Mark K Chan; Ralf Bauer; Matthias Kerl; Peter Hunold; Volkmar Jacobi; Ralf Bruder; Achim Schweikard; Dirk Rades; Thomas J Vogl; Peter Kleine; Frank Bode; Jürgen Dunst
Journal:  Cureus       Date:  2016-07-20

8.  Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams.

Authors:  H Immo Lehmann; Christian Graeff; Palma Simoniello; Anna Constantinescu; Mitsuru Takami; Patrick Lugenbiel; Daniel Richter; Anna Eichhorn; Matthias Prall; Robert Kaderka; Fine Fiedler; Stephan Helmbrecht; Claudia Fournier; Nadine Erbeldinger; Ann-Kathrin Rahm; Rasmus Rivinius; Dierk Thomas; Hugo A Katus; Susan B Johnson; Kay D Parker; Jürgen Debus; Samuel J Asirvatham; Christoph Bert; Marco Durante; Douglas L Packer
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

9.  Feasibility study on stereotactic radiotherapy for total pulmonary vein isolation in a canine model.

Authors:  Ji Hyun Chang; Myung-Jin Cha; Jeong-Wook Seo; Hak Jae Kim; So-Yeon Park; Byoung Hyuck Kim; Euijae Lee; Moo-Kang Kim; Hye-Sun Yoon; Seil Oh
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

10.  Analysis of Pulmonary Vein Antrums Motion with Cardiac Contraction Using Dual-Source Computed Tomography.

Authors:  Houda Bahig; Jacques de Guise; Toni Vu; Carl Chartrand-Lefebvre; Danis Blais; Martin Lebeau; Nhu-Tram Nguyen; David Roberge
Journal:  Cureus       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.